ERBB2 and breast carcinoma: Interestingly, FAM83A was also reported to be one of the highly tyrosine-phosphorylated proteins in Trastuzumab-resistant HER2-positive breast cancer cells, and again, FAM83A ablation suppressed the growth of Trastuzumab-resistant cells43.